However, tirzepatide causes more rapid weight loss in clinical trials, which could lead to greater lean mass loss if protein intake is inadequate
Welke optie het meest geschikt is, hangt af van individuele gezondheidsfactoren en moet altijd met een zorgverlener worden besproken
however, in many instances, treatment is long-term or lifelong, Shah explained
PMC (2019) Subcutaneous drug delivery: pharmacologic considerations and techniques American College of Cardiology (2025) REDEFINE 1 and REDEFINE 2 journal scan summary The Lancet (2023) Efficacy and safety of CagriSema in type 2 diabetes: phase 2 trial (Frias et al.) PMC (2024) Efficacy and safety of cagrilintide and CagriSema: systematic review and metaanalysis Pure Lab Peptides Cagrilintide (5 mg) product page (quality and batch documentation) Related research, protocols, and guides Explore the available research context, protocol variants or comparisons, and practical guides
Although these trials primarily enrolled individuals with relatively low DKD risk and were not designed to evaluate kidney outcomes specifically, exploratory analyses consistently indicated slower kidney disease progression across diverse eGFR and albuminuria levels [39-44]
GetReliefResponsibly.com, 2017)